Download
s41416-021-01577-6.pdf 1,20MB
WeightNameValue
1000 Titel
  • Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma
1000 Autor/in
  1. Öcal, Osman |
  2. Ingrisch, Michael |
  3. Ümütlü, Muzaffer Reha |
  4. Peynircioglu, Bora |
  5. Loewe, Christian |
  6. van Delden, Otto |
  7. Vandecaveye, Vincent |
  8. Gebauer, Bernhard |
  9. Zech, Christoph J. |
  10. Sengel, Christian |
  11. Bargellini, Irene |
  12. Iezzi, Roberto |
  13. Benito, Alberto |
  14. Pech, Maciej |
  15. Malfertheiner, Peter |
  16. Ricke, Jens |
  17. Seidensticker, Max |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-10-22
1000 Erschienen in
1000 Quellenangabe
  • 126(2):211-218
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1038/s41416-021-01577-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770679/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Aims!#!To investigate the prognostic value of baseline imaging features for overall survival (OS) and liver decompensation (LD) in patients with hepatocellular carcinoma (HCC).!##!Design!#!Patients with advanced HCC from the SORAMIC trial were evaluated in this post hoc analysis. Several radiological imaging features were collected from baseline computed tomography (CT) and magnetic resonance imaging (MRI) imaging, besides clinical values. The prognostic value of these features for OS and LD (grade 2 bilirubin increase) was quantified with univariate Cox proportional hazard models and multivariate Least Absolute Shrinkage and Selection Operator (LASSO) regression.!##!Results!#!Three hundred and seventy-six patients were included in this study. The treatment arm was not correlated with OS. LASSO showed satellite lesions, atypical HCC, peritumoral arterial enhancement, larger tumour size, higher albumin-bilirubin (ALBI) score, liver-spleen ratio <1.5, ascites, pleural effusion and higher bilirubin values were predictors of worse OS, and higher relative liver enhancement, smooth margin and capsule were associated with better OS. LASSO analysis for LD showed satellite lesions, peritumoral hypointensity in hepatobiliary phase, high ALBI score, higher bilirubin values and ascites were predictors of LD, while randomisation to sorafenib arm was associated with lower LD.!##!Conclusions!#!Imaging features showing aggressive tumour biology and poor liver function, in addition to clinical parameters, can serve as imaging biomarkers for OS and LD in patients receiving sorafenib and selective internal radiation therapy for HCC.
1000 Sacherschließung
lokal Female [MeSH]
lokal Aged [MeSH]
lokal Liver Neoplasms/diagnostic imaging [MeSH]
lokal Prognostic markers
lokal Humans [MeSH]
lokal Hepatocellular carcinoma
lokal Carcinoma, Hepatocellular/pathology [MeSH]
lokal Carcinoma, Hepatocellular/drug therapy [MeSH]
lokal Sorafenib/therapeutic use [MeSH]
lokal Carcinoma, Hepatocellular/diagnostic imaging [MeSH]
lokal Liver Neoplasms/pathology [MeSH]
lokal Article
lokal Male [MeSH]
lokal Liver/physiopathology [MeSH]
lokal Prognosis [MeSH]
lokal Antineoplastic Agents/therapeutic use [MeSH]
lokal Bilirubin/blood [MeSH]
lokal Magnetic Resonance Imaging/methods [MeSH]
lokal Tumor Burden [MeSH]
lokal Biomarkers, Tumor/analysis [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-5234-1921|https://orcid.org/0000-0003-0268-9078|https://frl.publisso.de/adhoc/uri/w5xtw7x0bMO8LCBNdXphZmZlciBSZWhh|https://frl.publisso.de/adhoc/uri/UGV5bmlyY2lvZ2x1LCBCb3Jh|https://frl.publisso.de/adhoc/uri/TG9ld2UsIENocmlzdGlhbg==|https://frl.publisso.de/adhoc/uri/dmFuIERlbGRlbiwgT3R0bw==|https://frl.publisso.de/adhoc/uri/VmFuZGVjYXZleWUsIFZpbmNlbnQ=|https://frl.publisso.de/adhoc/uri/R2ViYXVlciwgQmVybmhhcmQ=|https://frl.publisso.de/adhoc/uri/WmVjaCwgQ2hyaXN0b3BoIEou|https://frl.publisso.de/adhoc/uri/U2VuZ2VsLCBDaHJpc3RpYW4=|https://frl.publisso.de/adhoc/uri/QmFyZ2VsbGluaSwgSXJlbmU=|https://frl.publisso.de/adhoc/uri/SWV6emksIFJvYmVydG8=|https://frl.publisso.de/adhoc/uri/QmVuaXRvLCBBbGJlcnRv|https://frl.publisso.de/adhoc/uri/UGVjaCwgTWFjaWVq|https://frl.publisso.de/adhoc/uri/TWFsZmVydGhlaW5lciwgUGV0ZXI=|https://frl.publisso.de/adhoc/uri/Umlja2UsIEplbnM=|https://orcid.org/0000-0002-2481-5410
1000 Hinweis
  • DeepGreen-ID: 31e2ab2f7f76445ebced55b69a6db6b1 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6442864.rdf
1000 Erstellt am 2023-04-26T16:00:36.120+0200
1000 Erstellt von 322
1000 beschreibt frl:6442864
1000 Zuletzt bearbeitet Thu Oct 19 13:32:39 CEST 2023
1000 Objekt bearb. Thu Oct 19 13:32:39 CEST 2023
1000 Vgl. frl:6442864
1000 Oai Id
  1. oai:frl.publisso.de:frl:6442864 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source